That is not a very encouraging first statement from a Minister (who surely deserved to be better briefed), for a variety of reasons.
Firstly, while most of us may accept that, for the time being at least, some use of animals is unavoidable in some areas of medical research and testing, even a superficial scrutiny of what goes on today reveals that many animal experiments cannot satisfy the criterion of scientific necessity for justifiable purposes. The reduction in animal procedures that the 1986 Act was designed to achieve is not being delivered.
Secondly, whether or not the UK has the toughest legislation in the world is debatable, but, in any case, it is not the contents of laws, but the rigour with which they are applied, that is of paramount importance. Thus, it is of interest to note that, a few days before Ms Eagle's statement, the British Union for the Abolition of Vivisection (BUAV) reported 3 that the Government had backed down in the face of an application by the BUAV to the High Court for a judicial review on the failure of the Government to apply the 1986 Act by not insisting that in vitro procedures of proven value for the production of monoclonal antibodies must be used to replace the in vivo ascites procedure in mice. Other parts of the BUAV action concerned the general Three Rs principle of insisting on the application of replacement alternative methods which have been shown to be relevant and reliable, and on the continued use of the LD50 test in Great Britain. It appears that the Government agreed to pay the BUAV's costs in full, and to send out a notice to all licence holders permitted to produce monoclonal antibodies. The early revocation of some or all licences involving the ascites method should now be expected.
The continuous increase in the production and use of genetically modified animals ( Figure 1) is a matter of concern to which FRAME had repeatedly drawn attention. Yet, in the recently published, 54-page Animal Procedures Committee Report on Biotechnology, 4 there is no mention of ECVAM workshop report 28 on The Use of Transgenic Animals in the European Union 5 (although the workshop was attended by a Home Office Inspector as an observer), or of the 1999 ATLA supplement on The Production and Use of Transgenic Animals, 6 or of the ethical scheme for assessing the use of laboratory animals for biomedical pur-
Animal Procedures Remain Vital to Biomedical Research:
It ain't necessarily so . . . Editorial poses, produced by Delpire et al., 7 which focuses on transgenic animals. The same point could be made about a report on genetically modified animals, produced earlier this year by the Royal Society. 8 It has been put to me that the APC and the Royal Society do not want to publicise views that may conflict with their own. That is not FRAME's policy, and both reports will be reviewed fully in forthcoming issues of ATLA.
The best way out of this dilemma for the Government, if they could get away with it, would be to learn from the way in which unemployment statistics were massaged in the past, and to take some or all procedures involving genetically modified animals out of the annual statistics altogether, as has been suggested by the Royal Socety 8 and by the Research Defence Society. 9 But why stop at that? If they followed the US example and omitted all procedures involving rats, mice and birds from the Home Office statistics, they could claim to have presided over the most dramatic reduction in animal experimentation ever achieved, not only at home, but in any country! The FRAME position remains unaltered: not only should all production, maintenance and use of genetically modified animals continue to be recorded in the annual statistics, but the controls on such production, maintenance and use should be greatly strengthened and more rigorously enforced.
One of my concerns as a scientist who has always been supportive of the need to improve human health and to conquer and alleviate disease wherever possible, as well as being conscious of our collective responsibility to safeguard animal well-being, is the unsupportable hype and the breathtaking dishonesty that surround so many of the current claims concerning the genetic manipulation of animals. If some scientists are to be believed, were we to give them the greater freedom they desire, all diseases would soon be overcome, and we would all be able to live to well beyond 100.
Here is an example, albeit in another context. Earlier this week, on Sky News, I saw a reporter interview a kidney cancer patient on the lawn outside the Houses of Parliament, to ask him for his views on the latest medical breakthrough. The report then cut to a scientist sitting by a microscope at the Imperial Cancer Research Fund laboratories. He claimed that certain stem cells isolated from the human bone-marrow could be persuaded to develop into differentiated cells other than the blood cells normally produced there. This truly is a very exciting development (which should, by the way, have been enough to stop Parliament approv-1990
year number of procedures (thousands) 1991 1992 1993 1994 1995 1996 1997 1998 ing similar studies on human embryonic stem cells), but the overt implication that new kidneys for old would soon be available, was disgracefully misleading. Sometimes, at FRAME, we feel that we represent a lone voice which nobody wants to hear -we are not sufficiently antivivisectionist to contribute to the confrontations with which the media love to entertain us (or used to, before Big Brother and Survivors), nor sufficiently sold on science to be noticed by the Royal Society, the APC, etc. However, there is now eminent support for the kind of quality of critical review that we want brought into the arena -from Professor Richard Lewontin of Harvard University (an Establishment figure in an Establishment institution, who cannot be so easily brushed aside).
Much of the drive to genetically modify rodents (and even other animals, such as nonhuman primates), stems from the human genome project, but Lewontin, in an article entitled They got the wrong key of life, originally published in The New York Review of Books, and recently reprinted in The Sunday Times, 10 points out that, while gene mapping seemed to be the Holy Grail, "the big irony of the human genome project is that the result turns out not to provide the answer to the question that motivated the project" and that "scientists are realising that the real truth is hidden in our proteins".
Lewontin is forthright in his condemnation of the fashion which so rapidly enraptured science and government alike:
"Molecular biology has . . . become a religion, and molecular biologists are its prophets. For other intellectuals, the words are the matter, but scientists think of themselves as simply reporting objectively the facts of Nature. Like the Delphic oracle, they sit perched on their tripods, with upturned eyeballs, and out of their mouths issue Nature's words."
He says that it is now agreed that "the genome was not really the right target, and that we now need to study the proteome, the complete set of all the proteins manufactured by an organism". The problem is that the old cliché that "genes make proteins" is wrong -genes make polypeptides, which are further processed to make proteins, and the eventual functional proteins can be made up of the combined products of several genes. There are now calls for a proteome project to replace the genome project, but this will be much more complicated and will take much, much longer to complete.
Lewontin's analysis and ideas will be expounded more fully in It Ain't Necessarily So, which is to be published by Granta later this year, and to which I greatly look forward.
Meanwhile, I hope it will be considered permissible for me to urge the Government and its new Minister not to be too easily convinced by pseudoscientific arguments in favour of greater freedom to manipulate, distort and exploit the genomes, and thus the lifestyles and well-being, of our fellow mammals, in the pursuit of the latest version of the Holy Grail, remembering that it ain't necessarily so . . .
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